{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:16:43Z","timestamp":1789741003164,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.biopha.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T20:56:19Z","timestamp":1429131379000},"page":"52-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells"],"prefix":"10.1016","volume":"72","author":[{"given":"Ruonan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.04.005_bib0115","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2015.04.005_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2014.07.103","article-title":"Impact of obesity on surgical and oncologic outcomes in ovarian cancer","volume":"135","author":"Kumar","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ncb3110","article-title":"Reduced adenosine-to-inosine mir-455-5p editing promotes melanoma growth and metastasis","volume":"17","author":"Shoshan","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s13277-015-3136-5","article-title":"The functional sites of miRNAs and lncRNAs in gastric carcinogenesis","volume":"36","author":"Wan","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12929-015-0113-7","article-title":"Regulation of cancer metastasis by microRNAs","volume":"22","author":"Chan","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2015.04.005_bib0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yexcr.2014.08.006","article-title":"Downregulation of microRNA-498 in colorectal cancers and its cellular effects","volume":"330","author":"Gopalan","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2015.04.005_bib0150","doi-asserted-by":"crossref","first-page":"41297","DOI":"10.1074\/jbc.M112.407189","article-title":"1,25-Dihydroxyvitamin d3 suppresses telomerase expression and human cancer growth through microRNA-498","volume":"287","author":"Kasiappan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.04.005_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molonc.2013.10.001","article-title":"High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth","volume":"8","author":"Leivonen","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/ERC-13-0357","article-title":"A miRNA signature associated with human metastatic medullary thyroid carcinoma","volume":"20","author":"Santarpia","year":"2013","journal-title":"Endocrine-Relat. Cancer"},{"key":"10.1016\/j.biopha.2015.04.005_bib0165","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1158\/1078-0432.CCR-10-3068","article-title":"Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a","volume":"17","author":"Lin","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.04.005_bib0170","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.leu.2403111","article-title":"The phosphoinositide 3-kinase\/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin d1 expression","volume":"17","author":"Cappellini","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2015.04.005_bib0175","doi-asserted-by":"crossref","first-page":"249393","DOI":"10.1155\/2014\/249393","article-title":"The role of microRNAs in ovarian cancer","volume":"2014","author":"Kinose","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2015.04.005_bib0180","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/j.1582-4934.2010.01058.x","article-title":"The role of microRNAs in ovarian cancer initiation and progression","volume":"14","author":"Li","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2015.04.005_bib0185","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.biocel.2009.12.017","article-title":"Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications","volume":"42","author":"Mezzanzanica","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2013.00153","article-title":"The role of microRNAs in the tumorigenesis of ovarian cancer","volume":"3","author":"Di Leva","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13238-014-0121-5","article-title":"Threonine 32 (Thr32) of FOXO3 is critical for TGF-beta-induced apoptosis via Bim in hepatocarcinoma cells","volume":"6","author":"Zhao","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.biopha.2015.04.005_bib0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13277-014-2698-y","article-title":"Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2015.04.005_bib0205","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3892\/mmr.2014.2664","article-title":"Upregulation of forkhead box o3 transcription is involved in c2-ceramide induced apoptosis and autophagy in ovarian cancer cells in vitro","volume":"10","author":"Jin","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2015.04.005_bib0210","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s12032-012-0275-z","article-title":"The expression and prognosis of FOXO3a and skp2 in human ovarian cancer","volume":"29","author":"Lu","year":"2012","journal-title":"Med. Oncol. (Northwood, London, Engl.)"},{"key":"10.1016\/j.biopha.2015.04.005_bib0215","doi-asserted-by":"crossref","first-page":"e40607","DOI":"10.1371\/journal.pone.0040607","article-title":"Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2015.04.005_bib0220","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1128\/MCB.22.22.7842-7852.2002","article-title":"Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D","volume":"22","author":"Schmidt","year":"2002","journal-title":"Mol. Cell. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:55:15Z","timestamp":1760093715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":22,"alternative-id":["S0753332215000967"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.04.005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}